J. S. Stamler

Publication List Details

Period

1992 - 1992

Number

26

Co-Authors

Polynitrosylated proteins: characterization, bioactivity, and functional consequences.

Simon, D I, Mullins, M E, Jia, L, Gaston, B, Singel, D J, Stamler, J S

Chemical modification of proteins is a common theme in their regulation. Nitrosylation of protein sulfhydryl groups has been shown to confer nitric oxide (NO)-like biological activities and to...

Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells.

Asano, K, Chee, C B, Gaston, B, Lilly, C M, Gerard, C, Drazen, J M, ...

Histochemical activity and immunoreactivity of nitric oxide synthase (NOS, EC 1.14.13.39) have been recently demonstrated in human lung epithelium. However, the molecular nature of NOS and the...

S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds.

Stamler, J S, Simon, D I, Osborne, J A, Mullins, M E, Jaraki, O, Michel, T, ...

Endothelium-derived relaxing factor (EDRF) activity has been attributed to the highly labile nitric oxide radical (NO). In view of the fact that the plasma and cellular milieux contain reactive...

Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin.

Stamler, J S, Jaraki, O, Osborne, J, Simon, D I, Keaney, J, Vita, J, ...

We have recently shown that nitric oxide or authentic endothelium-derived relaxing factor generated in a biologic system reacts in the presence of specific protein thiols to form S-nitrosoprotein...

S-nitrosylation of tissue-type plasminogen activator confers vasodilatory and antiplatelet properties on the enzyme.

Stamler, J S, Simon, D I, Jaraki, O, Osborne, J A, Francis, S, Mullins, M, ...

Tissue-type plasminogen activator (t-PA) reacts upon exposure to endothelium-derived relaxing factor (EDRF) by way of the enzyme's single free sulfhydryl (Cys-83) to form a stable S-nitrosothiol...

NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties.

Keaney, J F, Simon, D I, Stamler, J S, Jaraki, O, Scharfstein, J, Vita, J A, ...

Recent evidence suggests that sulfhydryl species can react with oxides of nitrogen under physiologic conditions and thereby stabilize endothelium-derived relaxing factor (EDRF) activity, but the...

Inhibition of sphincter of Oddi function by the nitric oxide carrier S-nitroso-N-acetylcysteine in rabbits and humans.

Slivka, A, Chuttani, R, Carr-Locke, D L, Kobzik, L, Bredt, D S, Loscalzo, J, ...

Nitric oxide (NO) is an inhibitor of gastrointestinal smooth muscle. Model systems of the gut predict the NO will complex with biological thiol (SH) groups, yielding S-nitrosothiols (RS-NO), which...

In vivo transfer of nitric oxide between a plasma protein-bound reservoir and low molecular weight thiols.

Scharfstein, J S, Keaney, J F, Slivka, A, Welch, G N, Vita, J A, Stamler, J S, ...

Plasma albumin reacts with nitric oxide (NO) to form the bioactive adduct, S-nitroso-albumin (S-NO-albumin). The limited intracellular access of S-NO-albumin suggests the need for a vascular transfer...

Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen.

Stamler, J S, Osborne, J A, Jaraki, O, Rabbani, L E, Mullins, M, Singel, D, ...

Elevated levels of homocysteine are associated with an increased risk of atherosclerosis and thrombosis. The reactivity of the sulfhydryl group of homocysteine has been implicated in molecular...

Polynitrosylated proteins: characterization, bioactivity, and functional consequences.

Simon, D I, Mullins, M E, Jia, L, Gaston, B, Singel, D J, Stamler, J S

Chemical modification of proteins is a common theme in their regulation. Nitrosylation of protein sulfhydryl groups has been shown to confer nitric oxide (NO)-like biological activities and to...

Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells.

Asano, K, Chee, C B, Gaston, B, Lilly, C M, Gerard, C, Drazen, J M, ...

Histochemical activity and immunoreactivity of nitric oxide synthase (NOS, EC 1.14.13.39) have been recently demonstrated in human lung epithelium. However, the molecular nature of NOS and the...

S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds.

Stamler, J S, Simon, D I, Osborne, J A, Mullins, M E, Jaraki, O, Michel, T, ...

Endothelium-derived relaxing factor (EDRF) activity has been attributed to the highly labile nitric oxide radical (NO). In view of the fact that the plasma and cellular milieux contain reactive...

Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin.

Stamler, J S, Jaraki, O, Osborne, J, Simon, D I, Keaney, J, Vita, J, ...

We have recently shown that nitric oxide or authentic endothelium-derived relaxing factor generated in a biologic system reacts in the presence of specific protein thiols to form S-nitrosoprotein...

S-nitrosylation of tissue-type plasminogen activator confers vasodilatory and antiplatelet properties on the enzyme.

Stamler, J S, Simon, D I, Jaraki, O, Osborne, J A, Francis, S, Mullins, M, ...

Tissue-type plasminogen activator (t-PA) reacts upon exposure to endothelium-derived relaxing factor (EDRF) by way of the enzyme's single free sulfhydryl (Cys-83) to form a stable S-nitrosothiol...

NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties.

Keaney, J F, Simon, D I, Stamler, J S, Jaraki, O, Scharfstein, J, Vita, J A, ...

Recent evidence suggests that sulfhydryl species can react with oxides of nitrogen under physiologic conditions and thereby stabilize endothelium-derived relaxing factor (EDRF) activity, but the...

Inhibition of sphincter of Oddi function by the nitric oxide carrier S-nitroso-N-acetylcysteine in rabbits and humans.

Slivka, A, Chuttani, R, Carr-Locke, D L, Kobzik, L, Bredt, D S, Loscalzo, J, ...

Nitric oxide (NO) is an inhibitor of gastrointestinal smooth muscle. Model systems of the gut predict the NO will complex with biological thiol (SH) groups, yielding S-nitrosothiols (RS-NO), which...

In vivo transfer of nitric oxide between a plasma protein-bound reservoir and low molecular weight thiols.

Scharfstein, J S, Keaney, J F, Slivka, A, Welch, G N, Vita, J A, Stamler, J S, ...

Plasma albumin reacts with nitric oxide (NO) to form the bioactive adduct, S-nitroso-albumin (S-NO-albumin). The limited intracellular access of S-NO-albumin suggests the need for a vascular transfer...

Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen.

Stamler, J S, Osborne, J A, Jaraki, O, Rabbani, L E, Mullins, M, Singel, D, ...

Elevated levels of homocysteine are associated with an increased risk of atherosclerosis and thrombosis. The reactivity of the sulfhydryl group of homocysteine has been implicated in molecular...

Enhanced gastric nitric oxide synthase activity in duodenal ulcer patients.

Rachmilewitz, D, Karmeli, F, Eliakim, R, Stalnikowicz, R, Ackerman, Z, Amir, G, ...

Nitric oxide, the product of nitric oxide synthase in inflammatory cells, may have a role in tissue injury through its oxidative metabolism. Nitric oxide may have a role in the pathogenesis of...

Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease.

Rachmilewitz, D, Stamler, J S, Bachwich, D, Karmeli, F, Ackerman, Z, Podolsky, D K

Recent studies have suggested that nitric oxide (NO.), the product of nitric oxide synthase in inflammatory cells, may play a part in tissue injury and inflammation through its oxidative metabolism....